Data / Drug companies / Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc.: 24 products in the FDA NDC directory, labeler code 53489
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sun Pharmaceutical Industries, Inc. (labeler code 53489) lists 24 products in the FDA National Drug Code Directory, covering 11 finished drugs by generic name. By type: 24 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 12, 2013.
The request: Watch Sun Pharmaceutical Industries, Inc. (FDA labeler code 53489): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 53489
- Products in commercial distribution
- 24
- Packages
- 98
- Finished drugs by generic name
- 11
- Prescription products
- 24
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1
- Flagged as original packager
- 24 of 24 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 1
- Earliest marketing start
- July 10, 1986
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 24 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 24 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Doxycycline hyclate | 4 | 61 |
| Thioridazine hydrochloride | 4 | 5 |
| Spironolactone | 3 | 45 |
| Minoxidil | 2 | 113 |
| Albuterol sulfate | 2 | 46 |
| Sulfamethoxazole and trimethoprim | 2 | 48 |
| Sulindac | 2 | 8 |
| Allopurinol | 2 | 54 |
| Quinidine gluconate | 1 | 2 |
| Spironolactone and hydrochlorothiazide | 1 | 9 |
| Phentermine hydrochloride | 1 | 26 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 13 | 54.2% |
| Tablet, film coated | 8 | 33.3% |
| Capsule | 2 | 8.3% |
| Tablet, extended release | 1 | 4.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Phentermine Hydrochloride | 53489-676 | Tablet | Generic drugs (ANDA) | August 12, 2013 |
| Sulindac | 53489-479 | Tablet | Generic drugs (ANDA) | September 4, 2009 |
| Sulindac | 53489-478 | Tablet | Generic drugs (ANDA) | September 4, 2009 |
| Doxycycline Hyclate | 53489-647 | Tablet, film coated | Generic drugs (ANDA) | May 13, 2005 |
| Minoxidil | 53489-387 | Tablet | Generic drugs (ANDA) | December 14, 1995 |
| Minoxidil | 53489-386 | Tablet | Generic drugs (ANDA) | December 14, 1995 |
| Albuterol sulfate | 53489-177 | Tablet | Generic drugs (ANDA) | December 5, 1989 |
| Albuterol sulfate | 53489-176 | Tablet | Generic drugs (ANDA) | December 5, 1989 |
| Thioridazine Hydrochloride | 53489-500 | Tablet, film coated | Generic drugs (ANDA) | October 7, 1988 |
| Thioridazine Hydrochloride | 53489-150 | Tablet, film coated | Generic drugs (ANDA) | October 7, 1988 |
| Thioridazine Hydrochloride | 53489-149 | Tablet, film coated | Generic drugs (ANDA) | October 7, 1988 |
| Thioridazine Hydrochloride | 53489-148 | Tablet, film coated | Generic drugs (ANDA) | October 7, 1988 |
| Spironolactone and Hydrochlorothiazide | 53489-144 | Tablet | Generic drugs (ANDA) | July 2, 1987 |
| Quinidine Gluconate | 53489-141 | Tablet, extended release | Generic drugs (ANDA) | February 10, 1987 |
| Allopurinol | 53489-157 | Tablet | Generic drugs (ANDA) | January 9, 1987 |
| Allopurinol | 53489-156 | Tablet | Generic drugs (ANDA) | January 9, 1987 |
| Sulfamethoxazole and Trimethoprim | 53489-146 | Tablet | Generic drugs (ANDA) | August 25, 1986 |
| Sulfamethoxazole and Trimethoprim | 53489-145 | Tablet | Generic drugs (ANDA) | August 25, 1986 |
| Spironolactone | 53489-329 | Tablet, film coated | Generic drugs (ANDA) | July 23, 1986 |
| Spironolactone | 53489-328 | Tablet, film coated | Generic drugs (ANDA) | July 23, 1986 |
| Spironolactone | 53489-143 | Tablet | Generic drugs (ANDA) | July 23, 1986 |
| Doxycycline Hyclate | 53489-120 | Tablet, film coated | Generic drugs (ANDA) | July 10, 1986 |
| Doxycycline Hyclate | 53489-119 | Capsule | Generic drugs (ANDA) | July 10, 1986 |
| Doxycycline Hyclate | 53489-118 | Capsule | Generic drugs (ANDA) | July 10, 1986 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.